Top

Gepubliceerd in:

2006 | OriginalPaper | Hoofdstuk

11 Dementie en cognitieve stoornissen

Auteurs : R. Vandenberghe, A. Haekens

Gepubliceerd in: Handboek psychopathologie deel 2

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Het conventionele beeld van de ziekte van Alzheimer is dat van een onbehandelbare aandoening, die gepaard gaat met aantasting van instrumentele en basisactiviteiten van het dagelijks leven en waarvan de diagnose na uitsluiting gesteld wordt. De nadruk ligt dan ook op het tijdig voorzien in mantelzorg of residentiële zorg. In dit hoofdstuk belichten we aan de hand van voorbeelden enkele nieuwere aspecten van deze aandoening:

de chronologie, te beginnen bij het predementiële stadium;
de positieve klinische diagnostische kenmerken;
het praktische belang van de differentiële diagnose;
de behandelbaarheid van de aandoening.

vorige hoofdstuk 10 Psychoanalytische therapie

volgende hoofdstuk 12 Stoornissen door het gebruik van psychoactieve stoffen

Burns, A. e.a. (1999). The effects of donepezil in Alzheimer’s disease: Results from a multinational trial. Dementia and Geriatric Cognitive Disorders, 10, 237–244.PubMedCrossRef

Dautzenberg, P.L. J., Wouters, C. & Jonghe, J. de (2005). Medicamenteuze behandeling van gedragsstoornissen en psychische problemen bij dementie. Patient Care Neuropsychiatrie, 4, 15–24.

Feil, N. (1967). Group therapy in a home for the aged. Gerontologist, 7, 1, 192–195.PubMedCrossRef

Feldman, H. e.a. (2001). A 24-week randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease. Neurology, 57, 613–620.PubMedCrossRef

Gerdner L.A. (2000). Effects of individualized versus classical ‘relaxation’ music on the frequency of agitation in elderly persons with Alzheimer’s disease and related disorders. International Psychogeriatrics, 12, 49–65.PubMedCrossRef

Godderis, J., Ven, L. van de & Wils, V. (1992). Psychopathologische syndromen en stoornissen bij ouderen. In Handboek geriatrische psychiatrie. Leuven/Apeldoorn: Garant.

Hoogendijk, W. J.G. & Tilburg, W. van (2000). Delirium, dementie, amnestische en andere cognitieve stoornissen; psychische stoornissen veroorzaakt door een lichamelijke ziekte. In W. Vandereycken, C.A.L. Hoogduin & P.M.G. Emmelkamp (red.), Handboek psychopathologie deel 1 Basisbegrippen (pp. 55–96). Houten: Bohn Stafleu van Loghum.

Ivnik, R. J., Malec, J.F., Tangalos, E.G. e.a. (1990). The Auditory Verbal Learning test (AVLT): Norms for ages 55 years and older, Psychological Assessment, 2, 304–312.CrossRef

Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.P. & Bussche, H. van den (2005). Cholinesterase inhibitors for patients with Alzheimer’s disease: Systematic review of randomised clinical trials. British Medical Journal, 331, 321–327.PubMedCentralPubMedCrossRef

Kertesz, A.& Munoz, D. (1998). Pick’s Disease and Pick complex. New York: John Wiley. Lee, P.E., Gill, S.D., Freedman, M. e.a. (2004). Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review. British Medical Journal, 329, 75.

Lee, H.B. & Lyketsos, C.G. (2003). Depression in Alzheimer’s disease: Heterogeneity and related issues. Biological Psychiatry, 54, 353–362.PubMedCrossRef

Locascio, J.L., Growdon, J.H. & Corkin, S. (1995). Cognitive test performance in detecting, staging and tracking Alzheimer’s disease. Archives of Neurology, 52, 1087–1099.PubMedCrossRef

Lyketsos, C.G., Steele, C., Baker, L. e.a. (1997). Major and minor depression in Alzheimer’s disease: Prevalence and impact. Journal of Neuropsychiatry and Clinical Neuroscience, 9, 556–561.CrossRef

Lyketsos, C.G. e.a. (2001). Neuropsychiatric disturbance in Alzheimer’s disease clusters into three groups: The Cache County study. International Journal of Geriatric Psychiatry, 16, 1043–1053.PubMedCrossRef

Marien, P., Mampaey, E., Vervaet, A. e.a. (1998). Normative data for the Boston Naming test in native Dutch-speaking Belgian elderly. Brain & Language, 65, 447–467.CrossRef

Mesulam, M. (2000). Aging, Alzheimer’s disease and dementia: Clinical and neurobiological perspectives. In: M. Mesulam (Ed.), Principles of behavioural and cognitive neurology (pp. 439–522). Oxford: Oxford University Press.

Meulen, E.F. J., Schmand, B., Campen, J.P. van e.a. (2004). The seven minute screen: A neurocognitive screening test highly sensitive to various types of dementia. Journal of Neurology, Neurosurgery and Psychiatry, 75, 700–705.PubMedCentralPubMedCrossRef

Palsson, S. & Skoog, I. (1997). The epidemiology of affective disorders in the elderly: A review. Inernational Clinical Psychopharmacology, 7 (suppl 12), S3–13.CrossRef

Petersen, R.C. (2003). Mild cognitive impairment: Aging to Alzheimer’s disease. Oxford: Oxford University Press.

Piccininni, M., Di Carlo, A., Baldereschi, M. e.a. (2005). Behavioral and psychological symptoms in Alzheimer’s disease: Frequency and relationship with duration and severity of the disease. Dementia and Geriatric Cognitive Disorders, 19, 276–281.PubMedCrossRef

Qizilbash, N., Schneider, L.S., Chui, H. e.a. (2002). Evidence-based dementia practice. Oxford: Blackwell.

Rosso, S.M., Kaat, L.D., Baks, T. e.a. (2003). Frontotemporal dementia in the Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain, 126, 2016–2022.PubMedCrossRef

Scheltens, P., Fox, N., Barkhof, F. e.a. (2002). Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurology, 1, 13–21.PubMedCrossRef

Spector, A., Orrell, M., Davies S. e.a. (2000). Reality orientation for dementia. Cochrane Database of Systematic Reviews.

Sultzer, D.L. (2004). Psychosis and antipsychotic medications in Alzheimer’s disease: Clinical management and research perspectives. Dementia and Geriatric Cognitive Disorders, 17, 78–90.PubMedCrossRef

Tariot, P. e.a. (1998). Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. American Journal of Psychiatry, 155, 54–61.PubMedCrossRef

Tariot, P. e.a. (2004). Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. JAMA, 291, 317–324.PubMedCrossRef

Vandenberghe, R. & Tournoy, J. (2005). Cognitive aging and Alzheimer’s disease. Postgraduate Medical Journal, 81, 343–352.PubMedCentralPubMedCrossRef

Verkaik, R., van Weert, J.C. & Francke, A.L. (2005). The effects of psychosocial methods on depressed, agressive and apathetic behaviors of people with dementia: A systematic review. International Journal of Geriatric Psychiatry, 20, 301–314.PubMedCrossRef

Visser, P. J., Verhey, F.R., Ponds, R.W., Kester, A. & Jolles, J. (2000). Distinction between preclinical Alzheimer’s disease and depression. Journal of the American Geriatric Society, 48, 479–84.CrossRef

Visser, P. J., Verhey, F.R. J., Hofman, P.A.M. e.a. (2002). Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive complaints. Journal of Neurology, Neurosurgery and Psychiatry, 72, 491–497.PubMedCentralPubMed

Welsh, R. e.a. (1991). Detection of abnormal memory decline in mild cases of Alzheimer’s disease: Using CERAD neuropsychological measures. Archives of Neurology, 48, 278–281.PubMedCrossRef

Winblad, B., Engedal, K., Soininen, H. e.a. (2001). A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate Alzheimer’s disease. Neurology, 57, 489–495.PubMedCrossRef

Titel: 11 Dementie en cognitieve stoornissen
Auteurs: R. Vandenberghe
A. Haekens
Uitgeverij: Bohn Stafleu van Loghum
Boek: Handboek psychopathologie deel 2
Print ISBN: 978-90-313-4479-6

Elektronisch ISBN: 978-90-313-9244-5

Copyright: 2006
DOI: https://doi.org/10.1007/978-90-313-9244-5_11

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen